Leptin increases prostate cancer aggressiveness.

Area of Science:

• Endocrinology
• Oncology
• Nutritional Science

Background:

• Adipose tissue and adipocytokines (leptin, adiponectin) may influence prostate cancer (PCa) development.
• Leptin is hypothesized to promote PCa, while adiponectin may offer protection.

Purpose of the Study:

• To investigate the relationship between body composition, leptin, and adiponectin levels with PCa prevalence and aggressiveness in Argentinian men.

Main Methods:

• Study included 70 men (50-80 years): 35 healthy controls and 35 with PCa.
• PCa patients were subclassified by Gleason Score (GS).
• Methods included physical exams, ultrasounds, biopsies, blood tests (PSA, testosterone, leptin, adiponectin), and nutritional assessments.

Main Results:

• No significant differences in BMI or body fat percentage between PCa and control groups.
• Higher body fat mass was associated with more aggressive tumors (p=0.032).
• Leptin levels were higher in men with high GS (p<0.001), but not different between PCa and control groups.
• Adiponectin levels showed no significant association with PCa presence or aggressiveness.

Conclusions:

• Body composition and leptin levels are linked to prostate cancer aggressiveness, not prevalence.
• Findings suggest specific adipokines and body fat distribution may play a role in tumor progression.